Algernon Pharmaceuticals Inc (AGNPF)

[bettingonbayst]

I understand.

I believe the market will react favorably to "first patient dosed" news though, and here's why (in the lense of a gambler, we are talking about the otc/cse casino lol):

Investing pre clinical trial start: You have really 3 outcomes here,

1) drug works
2) drug doesn't work
3) Trial never starts

Investing post clinicacal trail start: You've got 2 outcomes,

1) drug works
2) drug doesn't work

...

In my experience, biotech stocks are very binary, and investing before a trail is very risky, but that can come with a much greater return as well. We still have 2 possibilities (one being greater) that could hinder our stock price:

Possibility - Trial never starts

Greater possibility - Trial get delayed

The market is very iffy on how legitimate management is here bc of past antics ie: the whey they handled the latest pp, the foolish spending of company money on advertising/promotion, etc. The market wants to see that they are more than just talk, more than just another cse penny stock jumping on the latest bandwagon. They have a real opportunity here to prove themselves.

I didn't feel overly confident watching that latest Proactive interview with Chris M. He seemed very somber and didn't exude much confidence, I hope it was just the day and nothing else, but my guard is up and a delay in the 2b/3 trial wouldn't surprise me one bit.

P. S. Thank you AMG for your continued insight, we may misread and poke from time to time, but the discussion is still appreciated.

B. O. B.